Description du projet
Une solution intelligente optimise l’allocation des ressources de soins de santé
Fournir des services de soins de santé de haute qualité de la manière la plus rentable et efficace repose sur le flux des patients. Il s’agit de la capacité à gérer efficacement des patients dans des délais minimaux. Il est nécessaire d’améliorer le flux des patients vers, dans et en dehors des hôpitaux afin de maximiser l’efficacité opérationnelle, ce qui constitue une priorité. Le projet Medical Express, financé par l’UE, développera une plateforme modulaire capable de s’intégrer facilement dans les structures informatiques actuelles et les dossiers médicaux électroniques. Recourant à la technologie de l’intelligence artificielle (IA), cette solution B2B destinée aux fournisseurs de soins de santé facilite l’analyse des données, l’établissement de rapports et la prise de décision. Déjà testée dans le secteur des soins primaires de Suède, cette solution guidée par l’IA a permis d’augmenter de 50 % le nombre de patients par jour, selon des généralistes.
Objectif
MedicalExpress (ME) is an AI-based innovation that optimises patient flow processes. It is a B2B solution for healthcare providers, developed to generate added value for patients and caregivers alike. ME is the result of 10 years of R&D together with clinicians, nurses and input from collaborators from academia, IT and pharma (e.g. Yale, Johns Hopkins, UCLA, ETH Zurich, Novo Nordisk and Sigma).electo
ME is currently implemented in 30% of Sweden’s public primary care, where is has proven to allow each general practitioner (GP) to see 50% more patients/day, generating cost savings on the order of €100 000 per GP/year. By increasing efficiency, ME increases access to care, improves patient safety and generates cost savings not only for payers, but also by decreasing work absenteeism.
Our offer is completely unique and the only CE-marked solution of its kind in Europe. ME is a comprehensive modular platform, which seamlessly integrates into existing IT structures and EHR (electronic health records). Being modular, ME can be fully customised to meet specific client needs. ME doesn’t replace jobs and retains diagnostic decision-making with experienced healthcare professionals. Our AI augments personnel in compiling and analysing data, creating reports and supporting decision-making in a way that liberates vital time that can be spent on tending after the patients. Having won several public tenders in competitions with international e-Health providers, we have demonstrated ME to be a great market fit as well as the most attractive solution to the prevailing resource management problem.
In the project, we will roll out the solution for several new market segments and launch or product throughout Europe and the US. The project will take our market-validated solution through a rapid market replication phase that will create >20 new jobs in the EU alone. 5 years after having penetrated into new market segments, we anticipate revenues on the order of €35M.
Champ scientifique
Programme(s)
Régime de financement
SME-2 - SME instrument phase 2Coordinateur
211 19 Malmo
Suède
L’entreprise s’est définie comme une PME (petite et moyenne entreprise) au moment de la signature de la convention de subvention.